Birdwatch Note
2024-03-05 07:06:22 UTC - MISINFORMED_OR_POTENTIALLY_MISLEADING
El cáncer Puede ser diferentes enfermedades que se caracterizan por el desarrollo de células anormales que se dividen sin control y tienen la capacidad de infiltrarse y destruir el tejido corporal. Visite a su médico y no haga caso de terapias alternativas. https://www.cancer.gov/espanol/cancer/naturaleza/que-es
Written by 5A57413725B19F57F14099CF68F0AB41532D1473394B9C3DBA109FB7C8D97407
Participant Details
Original Tweet
Tweet embedding is no longer reliably available, due to the platform's instability (in terms of both technology and policy). If the Tweet still exists, you can view it here: https://twitter.com/foo_bar/status/1764812779360243782
Please note, though, that you may need to have your own Twitter account to access that page. I am currently exploring options for archiving Tweet data in a post-API context.
All Information
- ID - 1764910308194181437
- noteId - 1764910308194181437
- participantId -
- noteAuthorParticipantId - 5A57413725B19F57F14099CF68F0AB41532D1473394B9C3DBA109FB7C8D97407
- createdAtMillis - 1709622382579
- tweetId - 1764812779360243782
- classification - MISINFORMED_OR_POTENTIALLY_MISLEADING
- believable -
- harmful -
- validationDifficulty -
- misleadingOther - 0
- misleadingFactualError - 0
- misleadingManipulatedMedia - 0
- misleadingOutdatedInformation - 0
- misleadingMissingImportantContext - 0
- misleadingUnverifiedClaimAsFact - 1
- misleadingSatire - 0
- notMisleadingOther - 0
- notMisleadingFactuallyCorrect - 0
- notMisleadingOutdatedButNotWhenWritten - 0
- notMisleadingClearlySatire - 0
- notMisleadingPersonalOpinion - 0
- trustworthySources - 1
- summary
- El cáncer Puede ser diferentes enfermedades que se caracterizan por el desarrollo de células anormales que se dividen sin control y tienen la capacidad de infiltrarse y destruir el tejido corporal. Visite a su médico y no haga caso de terapias alternativas. https://www.cancer.gov/espanol/cancer/naturaleza/que-es
Note Status History
| createdAt | timestampMillisOfFirstNonNMRStatus | firstNonNMRStatus | timestampMillisOfCurrentStatus | currentStatus | timestampMillisOfLatestNonNMRStatus | mostRecentNonNMRStatus | participantId |
| 2024-03-05 07:06:22 UTC (1709622382579) |
2024-03-06 01:27:57 UTC (1709688477603) |
CURRENTLY_RATED_HELPFUL | 2024-03-07 12:28:42 UTC (1709814522945) |
CURRENTLY_RATED_HELPFUL | 2024-03-06 01:27:57 UTC (1709688477603) |
CURRENTLY_RATED_HELPFUL |
Note Ratings
| rated at | rated by | |
| 2024-03-06 17:00:54 -0600 | Rating Details | |
| 2024-03-06 06:32:49 -0600 | Rating Details | |
| 2024-03-06 01:35:57 -0600 | Rating Details | |
| 2024-03-06 01:26:29 -0600 | Rating Details | |
| 2024-03-05 20:21:17 -0600 | Rating Details | |
| 2024-03-05 19:54:55 -0600 | Rating Details | |
| 2024-03-05 18:57:44 -0600 | Rating Details | |
| 2024-03-05 18:48:20 -0600 | Rating Details | |
| 2024-03-05 17:58:10 -0600 | Rating Details | |
| 2024-03-05 17:26:58 -0600 | Rating Details | |
| 2024-03-05 17:26:43 -0600 | Rating Details | |
| 2024-03-05 17:18:26 -0600 | Rating Details | |
| 2024-03-05 17:08:28 -0600 | Rating Details | |
| 2024-03-05 16:59:02 -0600 | Rating Details | |
| 2024-03-05 16:53:46 -0600 | Rating Details | |
| 2024-03-05 15:45:26 -0600 | Rating Details | |
| 2024-03-05 08:39:48 -0600 | Rating Details | |
| 2024-03-05 05:27:01 -0600 | Rating Details | |
| 2024-03-10 15:48:04 -0500 | Rating Details | |
| 2024-03-08 11:41:33 -0600 | Rating Details | |
| 2024-03-06 21:02:30 -0600 | Rating Details | |
| 2024-03-06 18:28:36 -0600 | Rating Details | |
| 2024-03-06 11:42:43 -0600 | Rating Details | |
| 2024-03-06 09:33:48 -0600 | Rating Details | |
| 2024-03-06 03:09:05 -0600 | Rating Details | |
| 2024-03-05 23:39:06 -0600 | Rating Details | |
| 2024-03-05 22:29:28 -0600 | Rating Details | |
| 2024-03-05 19:43:30 -0600 | Rating Details | |
| 2024-03-05 17:51:04 -0600 | Rating Details | |
| 2024-03-05 17:34:30 -0600 | Rating Details | |
| 2024-03-05 17:18:38 -0600 | Rating Details | |
| 2024-03-05 17:07:31 -0600 | Rating Details | |
| 2024-03-05 17:06:47 -0600 | Rating Details | |
| 2024-03-05 15:15:02 -0600 | Rating Details | |
| 2024-03-05 13:49:50 -0600 | Rating Details | |
| 2024-03-05 10:43:24 -0600 | Rating Details | |
| 2024-03-05 09:08:32 -0600 | Rating Details | |
| 2024-03-05 04:40:53 -0600 | Rating Details | |
| 2024-03-06 16:21:17 -0600 | Rating Details | |
| 2024-03-06 05:07:28 -0600 | Rating Details | |
| 2024-03-06 03:16:36 -0600 | Rating Details | |
| 2024-03-05 18:59:45 -0600 | Rating Details | |
| 2024-03-05 18:22:27 -0600 | Rating Details | |
| 2024-03-05 18:21:07 -0600 | Rating Details | |
| 2024-03-05 17:18:58 -0600 | Rating Details | |
| 2024-03-05 17:15:08 -0600 | Rating Details | |
| 2024-03-05 17:11:00 -0600 | Rating Details | |
| 2024-03-05 16:05:36 -0600 | Rating Details | |
| 2024-03-05 13:32:47 -0600 | Rating Details | |
| 2024-03-05 10:30:29 -0600 | Rating Details | |
| 2024-03-05 08:18:02 -0600 | Rating Details | |
| 2024-03-05 01:58:05 -0600 | Rating Details | |
| 2024-03-16 16:10:00 -0500 | Rating Details | |
| 2024-03-16 09:48:21 -0500 | Rating Details | |
| 2024-03-14 05:12:49 -0500 | Rating Details |